About this Journal Submit a Manuscript Table of Contents
Journal of Nanotechnology
Volume 2014 (2014), Article ID 854018, 7 pages
http://dx.doi.org/10.1155/2014/854018
Research Article

Pharmacokinetic and Tissue Distribution Study of Solid Lipid Nanoparticles of Zidovudine in Rats

Department of Pharmaceutics, Indian Institute of Technology, (Banaras Hindu University), Varanasi 221005, India

Received 31 July 2013; Revised 27 December 2013; Accepted 31 December 2013; Published 19 February 2014

Academic Editor: Jeffery L. Coffer

Copyright © 2014 Shah Purvin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. A. Fischl, D. D. Richman, N. Hansen et al., “The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial,” Annals of Internal Medicine, vol. 112, no. 10, pp. 727–737, 1990. View at Scopus
  2. G. J. Veal and D. J. Back, “Metabolism of zidovudine,” General Pharmacology, vol. 26, no. 7, pp. 1469–1475, 1995. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Singh, A. K. Dobhal, A. Jain, J. K. Pandit, and S. Chakraborty, “Formulation and evaluation of solid lipid nanoparticles of a water soluble drug: zidovudine,” Chemical and Pharmaceutical Bulletin, vol. 58, no. 5, pp. 650–655, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. J. das Neves, M. M. Amiji, M. F. Bahia, and B. Sarmento, “Nanotechnology-based systems for the treatment and prevention of HIV/AIDS,” Advanced Drug Delivery Reviews, vol. 62, no. 4-5, pp. 458–477, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. P. S. Kim and S. W. Read, “Nanotechnology and HIV: potential applications for treatment and prevention,” Wiley Interdisciplinary Reviews, vol. 2, no. 6, pp. 693–702, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Mallipeddi and L. C. Rohan, “Progress in antiretroviral drug delivery using nanotechnology,” International Journal of Nanomedicine, vol. 5, no. 1, pp. 533–547, 2010. View at Scopus
  7. P. R. Ravi, U. K. Kotreka, and R. N. Saha, “Controlled release matrix tablets of zidovudine: effect of formulation variables on the in vitro drug release kinetics,” AAPS PharmSciTech, vol. 9, no. 1, pp. 302–313, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Kuksal, A. K. Tiwary, N. K. Jain, and S. Jain, “Formulation and in vitro, in vivo evaluation of extended-release matrix tablet of zidovudine: influence of combination of hydrophilic and hydrophobic matrix formers,” AAPS PharmSciTech, vol. 7, no. 1, pp. E1–E9, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. C. D. Kaur, M. Nahar, and N. K. Jain, “Lymphatic targeting of zidovudine using surface-engineered liposomes,” Journal of Drug Targeting, vol. 16, no. 10, pp. 798–805, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. N. C. Phillips and C. Tsoukas, “Liposomal encapsulation of azidothymidine results in decreased hematopoietic toxicity and enhanced activity against murine acquired immunodeficiency syndrome,” Blood, vol. 79, no. 5, pp. 1137–1143, 1992. View at Scopus
  11. S. Jain, A. K. Tiwary, and N. K. Jain, “PEGylated elastic liposomal formulation for lymphatic targeting of zidovudine,” Current Drug Delivery, vol. 5, no. 4, pp. 275–281, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. U. Y. Nayak, S. Gopal, S. Mutalik et al., “Glutaraldehyde cross-linked chitosan microspheres for controlled delivery of Zidovudine,” Journal of Microencapsulation, vol. 26, no. 3, pp. 214–222, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Abu-Izza, L. Tambrallo, and D. R. Lu, “In vivo evaluation of zidovudine (AZT)-loaded ethylcellulose microspheres after oral administration in beagle dogs,” Journal of Pharmaceutical Sciences, vol. 86, no. 5, pp. 554–559, 1997. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Hillaireau, T. Le Doan, M. Appel, and P. Couvreur, “Hybrid polymer nanocapsules enhance in vitro delivery of azidothymidine-triphosphate to macrophages,” Journal of Controlled Release, vol. 116, no. 3, pp. 346–352, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. Y.-C. Kuo and H.-H. Chen, “Effect of nanoparticulate polybutylcyanoacrylate and methylmethacrylate-sulfopropylmethacrylate on the permeability of zidovudine and lamivudine across the in vitro blood-brain barrier,” International Journal of Pharmaceutics, vol. 327, no. 1-2, pp. 160–169, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. R. M. Mainardes, M. P. D. Gremião, I. L. Brunetti, M. D. Luiz Fonseca, and N. M. Khalil, “Pharmaceutical nanotechnology zidovudine-loaded PLA and PLA-PEG blend nanoparticles: influence of polymer type on phagocytic uptake by polymorphonuclear cells,” Journal of Pharmaceutical Sciences, vol. 98, no. 1, pp. 257–267, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Löbenberg, L. Araujo, H. Von Briesen, E. Rodgers, and J. Kreuter, “Body distribution of azidothymidine bound to hexyl-cyanoacrylate nanoparticles after i.v. injection to rats,” Journal of Controlled Release, vol. 50, no. 1–3, pp. 21–30, 1998. View at Publisher · View at Google Scholar · View at Scopus
  18. R. M. Mainardes, N. M. Khalil, and M. P. D. Gremião, “Intranasal delivery of zidovudine by PLA and PLA-PEG blend nanoparticles,” International Journal of Pharmaceutics, vol. 395, no. 1-2, pp. 266–271, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Dembri, M.-J. Montisci, J. C. Gantier, H. Chacun, and G. Ponchel, “Targeting of 3′-azido 3′-deoxythymidine (AZT)-loaded poly(isohexylcyanoacrylate) nanospheres to the gastrointestinal mucosa and associated lymphoid tissues,” Pharmaceutical Research, vol. 18, no. 4, pp. 467–473, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. P. M. Ved and K. Kim, “Poly(ethylene oxide/propylene oxide) copolymer thermo-reversible gelling system for the enhancement of intranasal zidovudine delivery to the brain,” International Journal of Pharmaceutics, vol. 411, no. 1-2, pp. 1–9, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. S. T. K. Narishetty and R. Panchagnula, “Transdermal delivery system for zidovudine: in vitro, ex vivo and in vivo evaluation,” Biopharmaceutics and Drug Disposition, vol. 25, no. 1, pp. 9–20, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. M. E. Brewster, W. R. Anderson, A. I. Webb et al., “Evaluation of a brain-targeting zidovudine chemical delivery system in dogs,” Antimicrobial Agents and Chemotherapy, vol. 41, no. 1, pp. 122–128, 1997. View at Scopus
  23. Y. Jin, N. Qi, L. Tong, and D. Chen, “Self-assembled drug delivery systems. Part 5: self-assemblies of a bolaamphiphilic prodrug containing dual zidovudine,” International Journal of Pharmaceutics, vol. 386, no. 1-2, pp. 268–274, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Chakraborty, D. Shukla, B. Mishra, and S. Singh, “Lipid—an emerging platform for oral delivery of drugs with poor bioavailability,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 73, no. 1, pp. 1–15, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Zur Mühlen, C. Schwarz, and W. Mehnert, “Solid lipid nanoparticles (SLN) for controlled drug delivery—drug release and release mechanism,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 45, no. 2, pp. 149–155, 1998. View at Publisher · View at Google Scholar · View at Scopus
  26. R. H. Müller, K. Mäder, and S. Gohla, “Solid lipid nanoparticles (SLN) for controlled drug delivery—a review of the state of the art,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 50, no. 1, pp. 161–177, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Uner and G. Yener, “Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives,” International Journal of Nanomedicine, vol. 2, no. 3, pp. 289–300, 2007.